HKUMed–Tsinghua team develops first-in-class broad-spectrum small-molecule antiviral to combat SARS-CoV-2 and related coronaviruses
HKUMed–Tsinghua team develops first-in-class broad-spectrum small-molecule antiviral to combat SARS-CoV-2 and related coronaviruses
calendar_today
June 25, 2026
domain
hku